Using the CO2 laser in oculoplastic surgery

Article

Over the past five years, we have successfully performed oculoplastic surgery on several hundred patients at the Belgian Ocular Laser Center (BOLC; www.BOLC.org) in Ghent, Belgium and, during this time, I have found the CO2 laser to provide an excellent alternative to the scalpel for treating the eyelids. Finally, we can offer bloodless surgery and improved outcomes.

Over the past five years, we have successfully performed oculoplastic surgery on several hundred patients at the Belgian Ocular Laser Center (BOLC; http://www.BOLC.org/) in Ghent, Belgium and, during this time, I have found the CO2 laser to provide an excellent alternative to the scalpel for treating the eyelids. Finally, we can offer bloodless surgery and improved outcomes.

The major indications for this laser include blepharoplasty, entropion, ectropion, ptosis of the upper eyelid and xanthelasmata. We do not, however, use this type of laser for skin resurfacing because we strongly believe that the Erbium:YAG laser is a better and safer option for superficial skin tissue ablation.

Understanding the physics

Laser energy is a single wavelength and the CO2 laser, which is at a wavelength of 10,600 nm, is strongly absorbed by water (a chromophore). The CO2 laser is an infrared laser and, as such, can only be delivered through an articulated arm. It is important to note, however, that if the aiming beam is coaxial in nature, one must ensure that this beam and the infrared beam are exactly aligned, by testing the laser on a tongue blade prior to surgery.

What do you need to get started?

We currently use the Coherent UltraPulse CO2 laser (Lumenis), the ultrapulse mode of which is characterized by pulses of high peak power, delivered in rapid sequence, which are sustained over the entire duration of the pulse. This modality is used to make the skin incision. The constant wave modality, on the other hand, produces continuously applied light with no variation over time, to incise conjunctiva and to dissect tissue.

Certain safety issues must be taken into consideration when performing this procedure and it is imperative that a notice, advising that laser surgery is in progress, is posted outside of the surgical suite in order to eliminate the chance of being disturbed.

surgical field.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.